Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 6: AMD I

08:00 - 09:30 | 21 September | Room: Room D1.

Back to Previous

08:00Clinical characteristics of the Charles Bonnet syndrome in patients with neovascular agerelated macular degeneration: The importance of early detection
P. Cardoso Portugal
08:06A realworld study to monitor wet agerelated macular degeneration patients treated with intravitreal aflibercept: 12month outcomes of RAINBOW stratified by treatment regimen
S. Baillif France
08:12Complement C5 inhibition as a potential treatment for geographic atrophy secondary to dry agerelated macular degeneration
J. Monés Spain
08:18Imaging characteristics of pigment epithelial detachments associated with neovascular age related macular degeneration and their response to intravitreal aflibercept therapy
S. Doguizi Turkey
08:24The effect of corticosteroids on human choroidal endothelial cells: a model to study central serous chorioretinopathy
E. van Dijk Netherlands
08:30Evaluation of polypoidal choroidal vasculopathy with Bscan flow images of swept source optical coherence tomography angiography
A. Fujita Japan
08:36Treatment patterns of ranibizumab 0.5 mg over time in treatmentnaïve patients with neovascular agerelated macular degeneration: results from LUMINOUS™, a global realworld study
M. Figueroa Spain
08:42Evaluation of indocyanine green angiographic features in symptomatic macular polypoidal choroidal vasculopathy over 24 months: results from the EVEREST II study
C. Tan Singapore
08:48Natural history of geographic atrophy secondary to age-related macular degeneration: Proxima A data from the 1year analysis of 100 patients
G. Staurenghi Italy
08:54Darkadapted two color funduscontrolled perimetry and multimodal imaging to correlate structure and function in neovascular agerelated macular degeneneration
L. von der Emde Germany
09:00LADDER trial of the port delivery system for ranibizumab: Preliminary study results
C. Awh United States
09:064 year “real world” outcomes of intravitreal Aflibercept for ARMD in Glasgow
J. Hind United Kingdom
09:12PERSEUS 24month analysis: A prospective noninterventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in patients with wet agerelated macular degeneration
N. Eter Germany
09:183 years audit comparing the results of visual outcome, treatment frequency and number of visits using ranibizumab prn vs ranibizumab treat and extend vs aflibercept (as per license in UK) in patients with neovascular agerelated macular degeneration
P. Prakash United Kingdom
Back to Previous

Sign up to EURETINA


© EURETINA All rights reserved
Loading please wait